Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine
PHASE2CompletedINTERVENTIONAL
Enrollment
104
Participants
Timeline
Start Date
November 30, 2013
Primary Completion Date
February 6, 2018
Study Completion Date
February 28, 2018
Conditions
Pancreatic Cancer
Interventions
DRUG
gemcitabine
DRUG
abraxane
DRUG
hydroxychloroquine
Trial Locations (1)
15232
Hillman Cancer Center, Pittsburgh
All Listed Sponsors
lead
Nathan Bahary, MD
OTHER
NCT01978184 - Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine | Biotech Hunter | Biotech Hunter